Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Neuroradiology|May 1, 1997
MRI of intramedullary sarcoidosis: follow-up of a caseE Waubant, C Manelfe, A Bonafé, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 2, 2001
IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosisE Waubant, L Gee, K Miller, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 17, 2008
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosisA Gajofatto, P Bacchetti, B Grimes, et al.Neurology|September 17, 1999
A pilot study of MRI activity before and during interferon beta-1a therapyE Waubant, D E Goodkin, R Sloan, et al.Neurology|September 13, 2006
Are initial demyelinating event recovery and time to second event under differential control?T West, M Wyatt, A High, et al.Archives of Neurology|September 17, 1999
Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disabilityP B Andersson, E Waubant, L Gee, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1995
T cell gelatinases mediate basement membrane transmigration in vitroD Leppert, E Waubant, R Galardy, et al.Annals of Neurology|December 1, 1996
Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosisD Leppert, E Waubant, M R Bürk, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 11, 2008
The onset location of multiple sclerosis predicts the location of subsequent relapsesE M Mowry, S Deen, I Malikova, et al.Neurology|February 18, 2009
Demyelinating events in early multiple sclerosis have inherent severity and recoveryE M Mowry, M Pesic, B Grimes, et al.Pageof 6